COMMUNIQUÉS West-GlobeNewswire

Ohr Pharmaceutical Regains Compliance with NASDAQ Listing Requirements

21/02/2019 - 16:45

NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) today announced that it received notice from The Nasdaq Stock Market LLC indicating that the Company has regained compliance with the [...]

Nova Leap Health Corp. Named #10 2019 TSX Venture Performer

21/02/2019 - 16:42

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- NOVA [...]

Tabula Rasa HealthCare Announces Launch and Location of New Scientific Precision Pharmacotherapy Research & Development Institute

21/02/2019 - 16:33

MOORESTOWN, N.J. and ORLANDO, Fla., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced the [...]

Mapi Pharma to Host Key Opinion Leader Meeting on Long Acting Glatiramer Acetate (GA Depot) for Primary Progressive Multiple Sclerosis and New Treatments for MS

21/02/2019 - 16:30

Analyst Lunch and Live Webcast on Tuesday, March 5th at 12 Noon ET NESS ZIONA, Israel, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, clinical late stage biopharmaceutical company, announced [...]

Xbrane Biopharma AB: Alessandro Sidoli and Saeid Esmaeilzadeh decline re-election for 2019

21/02/2019 - 16:21

Press release 2019-02-21 Xbrane Biopharma AB (publ) (" Xbrane ") has today been informed by the Nomination Committee that Alessandro Sidoli and Saeid Esmaeilzadeh have declined re-election at the Annual General Meeting [...]

Rebirth of a Heart Valve: Franciscan Health Surgeon First in World to Use Device

21/02/2019 - 16:00

Clinical Trial Tests Advanced Application of an ECM® Cardiac Valve at Heart Center INDIANAPOLIS, Indiana, Feb. 21, 2019 (GLOBE NEWSWIRE) -- A patient who received a first-in-the-world tricuspid valve procedure as part [...]

MolecularMD is acquired by ICON

21/02/2019 - 16:00

PORTLAND, Ore. and CAMBRIDGE, Mass., Feb. 21, 2019 (GLOBE NEWSWIRE) -- MolecularMD Corporation, a molecular diagnostic specialty laboratory that enables the development and commercialisation of precision medicines in [...]

Acasti Pharma Recognized in TSX Venture Exchange’s 2019 Venture 50

21/02/2019 - 15:15

LAVAL, Quebec, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]

VIDEO: Aleafia Health Named Top Performing Company of the Year for TSX Venture 50

21/02/2019 - 15:05

Aleafia Health Ranks First Based on Key Market Performance Measures Among all TSXV Listed Companies First Time a Cannabis Company has Achieved Top Performing Company Honours TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- [...]

EB Research Partnership Announces the 2nd Annual Plunge for Elodie on March 2 in Wellesley

21/02/2019 - 15:04

Polar Plunge Event Following Rare Disease Day Makes Big Waves for “Butterfly Children” with the Life-Threatening Skin Disease Epidermolysis Bullosa BOSTON, Feb. 21, 2019 (GLOBE NEWSWIRE) -- EB Research Partnership (EBRP [...]

DLT Resolution Selected as Primary Provider for Voice, Data and LTE Failover Services for the Chain of Leggat Auto Dealerships in Canada

21/02/2019 - 15:04

Las Vegas, NV, Feb. 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- DLT Resolution Inc. (OTC: DLTI), a Distributed Ledger Technology (“Blockchain”) Voice and Data and Information Technology company, is pleased to [...]

ATW Tech Announces Revenue Growth of 35% for VuduMobile in 2018

21/02/2019 - 15:00

MONTREAL, Feb. 21, 2019 (GLOBE NEWSWIRE) -- ATW Tech Inc. (“ATW Tech”) ( TSX-V: ATW ) is pleased to announce that its VuduMobile division (‘Vudu’) has had a very successful year in 2018 with a 35% increase in its [...]

ATW Tech annonce une croissance des revenus de 35% de VuduMobile en 2018

21/02/2019 - 15:00

MONTRÉAL, 21 févr. 2019 (GLOBE NEWSWIRE) -- ATW Tech Inc. (« ATW Tech » ou la « Société ») (TSX-V : ATW) est heureuse d'annoncer que sa division VuduMobile (« Vudu ») a connu une année exceptionnelle en 2018 avec une [...]

bioLytical Laboratories Earns MDSAP Certification, Highest Quality Standard in Medical Device Industry

21/02/2019 - 15:00

Audits confirm bioLytical’s Quality Management System fulfils latest standards for multiple regulatory jurisdictions including US FDA and Health Canada. RICHMOND, British Columbia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- [...]

4 Companies Shaping The CBD-Infused Beverage Industry

21/02/2019 - 15:00

VANCOUVER, British Columbia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- With the global CBD movement supercharged by the 2018 U.S. Farm Bill , cannabis and beverage companies alike are officially beginning to launch CBD-infused [...]

Agritek Holdings, Inc. Announces Upcoming CEO Webcast Interview Discussing Initial Order of 25,000 Units With Colorado's Top Selling Cannabis Edibles Brand, Mountain High Suckers, for Puerto Rico Through Exclusive Licensee 1919 Clinic

21/02/2019 - 15:00

LOS ANGELES, CA, Feb. 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and brand licensor for the [...]

Catalyst Pharmaceuticals Responds to Letter from Senator Bernie Sanders

21/02/2019 - 15:00

CORAL GABLES, Fla., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]

Alphatec to Report Fourth Quarter and Fiscal Year 2018 Financial Results on March 7, 2019

21/02/2019 - 15:00

CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”) announced today that the Company plans to release its fourth quarter and fiscal year 2018 [...]

Amgen, Cytokinetics and Servier Announce Start of METEORIC-HF, the Second Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure

21/02/2019 - 14:30

THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif. and SURESNES, France, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Amgen (NASDAQ: AMGN), Cytokinetics, Incorporated (NASDAQ: CYTK) and Servier today announced that METEORIC-HF [...]